US Patent Issued to YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM on Aug. 25 for "Liposomal formulations comprising AT1 receptor blockers and uses thereof" (Israeli Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,669, issued on Aug. 25, was assigned to YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (Jerusalem).

"Liposomal formulations comprising AT1 receptor blockers and uses thereof" was invented by Yechezkel Barenholz (Jerusalem), Ahuva Cern (Modiin, Israel) and Amiram Goldblum (Tel Aviv, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides liposomal formulations comprising a lipid membrane comprising at least one liposome forming phospholipid and a sterol; and an intraliposomal aqueous compartment encapsulating at least one ATI receptor blocker (ARB) and a pH-dependent ionizable anion; with t...